Consumer health products containing cannabinoids and deemed unapproved drugs in the US aren’t limited to products marketed as dietary supplements. The Food and Drug Administration has warned a contract manufacturer and another firm about making OTC drugs with cannabinoids.
The firms, BioLyte Laboratories LLC and Honest Globe Inc
Additionally, the letters published on 22 March warned the firms about good manufacturing practices